Commercial Development of Organ-on-a-chip Systems – Challenges and Strategies

Video   Oct 18, 2016


Organ-on-a-chip has been a field of strongly increasing academic activity in recent years with a clear pathway towards industrial applications, namely in the pharmaceutical industry but also as tools in Life Science research. As in many other lab-on-a-chip areas however, there is a substantial barrier in the transition from academic results to a commercial product development. This presentation will highlight critical points along this transition and indicate approaches to overcome these challenges. We will present different examples of organ-on-a-chip devices with special emphasis on issues of manufacturability and scalability, taking the interaction of materials, surfaces and cells in these devices into account.


Recommended Videos

LC-MS/MS for Bioanalytical Peptide and Protein Quantification: MS Considerations


Caitlin Dunning, Associate Scientist, discusses how to use mass spectrometry to develop sensitive, selective, and robust quantification methods for peptide and protein quantification, including: basic mass spectrometry considerations, MS tuning, and best practices for success.


Now you can visualize and analyze complex 3D cell models – with Harmony 4.8 software


See what you’re missing with the new capabilities of Harmony® 4.8 software for imaging, analysis, and visualization of complex 3D cell models.


Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis


Kelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS.



Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free


We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy